Fierce Pharma January 2, 2024
While public and political scrutiny around drug pricing has reached a fever pitch in the wake of 2022’s Inflation Reduction Act (IRA), that hasn’t stopped pharma majors from ringing in 2024 with their favorite New Year tradition: a hefty round of medication price hikes.
Altogether, companies such as Pfizer, Sanofi and Takeda are raising prices on more than 500 drug doses and formulations this month, Reuters first reported, citing data and analysis from research outfit 3 Axis Advisors and the related drug pricing non-profit 46brooklyn.
Taking different doses and formulations out of the mix, more than 140 medicine brands will see their prices increase in January, according to the news service.
Once again, Pfizer stood out among its peers...
Today's Sponsors
Today's Sponsor